BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8620490)

  • 1. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G; Crean SJ; Naik P; Kapas S
    Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
    Hembree JR; Agarwal C; Eckert RL
    Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not.
    Okazaki R; Conover CA; Harris SA; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1995 May; 10(5):788-95. PubMed ID: 7639114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK; Hu C; Baker VV
    Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.
    Steller MA; Delgado CH; Zou Z
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11970-4. PubMed ID: 8618825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.
    Bergmann U; Funatomi H; Yokoyama M; Beger HG; Korc M
    Cancer Res; 1995 May; 55(10):2007-11. PubMed ID: 7743492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
    Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
    Chen SC; Chou CK; Wong FH; Chang CM; Hu CP
    Cancer Res; 1991 Apr; 51(7):1898-903. PubMed ID: 2004373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells.
    Telford NA; Hogan A; Franz CR; Schultz GA
    Mol Reprod Dev; 1990 Oct; 27(2):81-92. PubMed ID: 1701096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
    Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
    Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.